A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy.

Levin LA, Bhatti MT, Klier S, Morgenstern R, Szanto D, Miller NR, Kupersmith MJ, Quark NAION Study Group

Open source

DOI
10.1016/j.ophtha.2025.07.039
Published
2026 Jan
Container
Ophthalmology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ophtha.2025.07.039,
  title = {A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy.},
  author = {Levin LA and Bhatti MT and Klier S and Morgenstern R and Szanto D and Miller NR and Kupersmith MJ and Quark NAION Study Group},
  year = {2026},
  journal = {Ophthalmology},
  doi = {10.1016/j.ophtha.2025.07.039},
  url = {https://doi.org/10.1016/j.ophtha.2025.07.039}
}

RIS

TY  - JOUR
TI  - A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy.
AU  - Levin LA
AU  - Bhatti MT
AU  - Klier S
AU  - Morgenstern R
AU  - Szanto D
AU  - Miller NR
AU  - Kupersmith MJ
AU  - Quark NAION Study Group
PY  - 2026
JO  - Ophthalmology
DO  - 10.1016/j.ophtha.2025.07.039
UR  - https://doi.org/10.1016/j.ophtha.2025.07.039
ER  - 

APA

LA, L., MT, B., S, K., R, M., D, S., NR, M., MJ, K., & Group, Q. N. S. (2026). A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy.. Ophthalmology. https://doi.org/10.1016/j.ophtha.2025.07.039

Source records